Menu
GeneBe

LMX1A

LIM homeobox transcription factor 1 alpha, the group of LIM class homeoboxes

Basic information

Region (hg38): 1:165201866-165356715

Previous symbols: [ "LMX1" ]

Links

ENSG00000162761NCBI:4009OMIM:600298HGNC:6653Uniprot:Q8TE12AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant nonsyndromic hearing loss 7 (Strong), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss 7 (Limited), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss 7 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal dominant 7ADAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic29754270

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LMX1A gene.

  • not provided (21 variants)
  • Inborn genetic diseases (11 variants)
  • Autosomal dominant nonsyndromic hearing loss 7 (9 variants)
  • LMX1A-related condition (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMX1A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
5
clinvar
6
missense
1
clinvar
17
clinvar
18
nonsense
1
clinvar
2
clinvar
3
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
14
clinvar
14
Total 2 3 17 1 19

Highest pathogenic variant AF is 0.00000657

Variants in LMX1A

This is a list of pathogenic ClinVar variants found in the LMX1A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-165203923-A-G Sensorineural hearing loss disorder • Autosomal-Recessive Hereditary Hearing Impairment Conflicting classifications of pathogenicity (Feb 12, 2020)517667
1-165203936-C-T not specified Uncertain significance (Aug 12, 2021)2221388
1-165203969-C-T not specified Uncertain significance (May 05, 2023)2544641
1-165203979-A-G Autosomal dominant nonsyndromic hearing loss 7 Benign (Aug 19, 2021)1294826
1-165204004-T-C not specified Uncertain significance (May 15, 2023)2546307
1-165204008-C-G not specified Uncertain significance (Mar 02, 2023)2493090
1-165204035-C-T not specified Uncertain significance (Mar 20, 2023)2525464
1-165205722-C-T Benign (May 13, 2021)1236257
1-165205901-G-A LMX1A-related disorder Benign (May 20, 2019)777953
1-165205914-C-T LMX1A-related disorder Uncertain significance (Sep 28, 2022)2636020
1-165205915-G-A Autosomal dominant nonsyndromic hearing loss 7 Likely pathogenic (May 31, 2023)2503455
1-165205954-G-T not specified Uncertain significance (Aug 02, 2021)2213477
1-165205969-T-G LMX1A-related disorder Likely benign (Jul 21, 2022)3048621
1-165205978-C-T Autosomal dominant nonsyndromic hearing loss 7 Uncertain significance (Aug 24, 2022)2433492
1-165205980-G-A not specified Uncertain significance (Sep 06, 2022)2310750
1-165206003-C-T not specified Uncertain significance (Dec 18, 2023)3119452
1-165206034-G-A not specified Uncertain significance (Jan 17, 2024)3119451
1-165206137-G-A Benign (May 12, 2021)1294822
1-165207933-T-C Benign (May 12, 2021)1294821
1-165208094-T-TTGC LMX1A-related disorder Likely benign (May 03, 2023)3029574
1-165208114-G-A Likely pathogenic (Feb 22, 2023)2576012
1-165210637-C-A Benign (May 14, 2021)1244331
1-165210694-G-A LMX1A-related disorder Likely benign (Jan 01, 2024)3024964
1-165210702-C-T LMX1A-related disorder Likely benign (May 13, 2019)3042090
1-165210725-C-G Autosomal dominant nonsyndromic hearing loss 7 Pathogenic (Feb 12, 2020)812515

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LMX1Aprotein_codingprotein_codingENST00000342310 8154849
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9910.00886125725061257310.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.001752160.8080.00001142500
Missense in Polyphen5691.7570.610311036
Synonymous0.5658288.80.9240.00000482725
Loss of Function4.06223.00.08700.00000132232

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0001390.000139
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a transcriptional activator by binding to an A/T-rich sequence, the FLAT element, in the insulin gene promoter. Required for development of the roof plate and, in turn, for specification of dorsal cell fates in the CNS and developing vertebrae (By similarity). {ECO:0000250}.;
Pathway
Dopaminergic Neurogenesis (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.0623
rvis_EVS
-0.74
rvis_percentile_EVS
13.94

Haploinsufficiency Scores

pHI
0.370
hipred
Y
hipred_score
0.699
ghis
0.510

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.986

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Lmx1a
Phenotype
integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; taste/olfaction phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; pigmentation phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype;

Gene ontology

Biological process
regulation of cell growth;axon guidance;memory;locomotory behavior;dentate gyrus development;cerebellum development;olfactory behavior;negative regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;synapse organization;dopaminergic neuron differentiation;midbrain dopaminergic neuron differentiation
Cellular component
nucleus
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;metal ion binding